David Uriel Ayllón Álvarez, Mariana Neri Calixto, César Humberto Aparicio Albarrán, Hugo Mendieta Zerón
  MNJ, pp. 140-145  



Background: Amyotrophic lateral sclerosis (ALS) is a rare chronic degenerative disease. The only approved treatment, Riluzole, is not available and is not economically affordable for most patients.

Objective: To report here a case of a pregnant woman 27 years of age with ALS, confirmed through electromyography. After spontaneous abortion and 88 days without clinical improvement and dependent on mechanical ventilation, treatment with autologous stem cell transplantation and immunomodulation was decided upon for the patient.

Methods: The patient received a daily subcutaneous (s.c.) dose of 300 μg human Granulocyte-Colony stimulating factor for a period of 3 days. Peripheral blood mononuclear cells were isolated by leukapheresis. These cells were self-transplanted to the patient 5 cc via lumbar puncture and 5 cc intravenously (i.v.). The immunomodulation treatment was based on the surface-fixation method.

Results: The patient remained hospitalized for an additional 249 days, at which time when she was contrareferred to a secondary-level health institution.

Conclusion: A treatment scheme combining ASCT (Autologous Stem Cell Transplantation) and immunomodulation, based on the surface-fixation method, could be an option to get a large period of no progression stage in ALS.


Amyotrophic lateral sclerosis, autologous stem cell transplantation, puerperium, surface-fixation method.

Full Text:



Sorenson EJ. The electrophysiology of the motor neuron diseases Neurol Clin; 2012. 30(12):605-620. DOI: 10.1016/j.ncl.2011.12.006

Mehta P, Kaye W, Bryan L, Larson T, Copeland T, Wu J, et al. Prevalence of amyotrophic lateral sclerosis - United States 2012-2013. Morb Mortal Wkly Rep Surveill Summ Wash DC 2002; 2016. 65(8):1-12. DOI: 10.15585/mmwr.ss6508a1

Poppe L, Rué L, Robberecht W, Van Den Bosch L. Translating biological findings into new treatment strategies for Amyotrophic Lateral Sclerosis (ALS). Exp Neurol; 2014. 262 Pt B:138-151.

DOI: 10.1016/j.expneurol.2014.07.001

Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial «Clinical limits of amyotrophic lateral sclerosis» workshop contributors. J Neurol Sci; 1994. 124 Suppl:96-107. DOI: 10.1016/0022-510x(94)90191-0

Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Mot Neuron Disord; 2000. 1(5):293-299.

DOI: 10.1080/146608200300079536

de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol; 2008. 119(3):497-503. DOI: 10.1016/j.clinph.2007.09.143

Paillisse C, Lacomblez L, Dib M, Bensimon G, Garcia-Acosta S, Meininger V. Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole. Amyotroph Lateral Scler Mot Neuron Disord; 2005. 6(1):37-44.

DOI: 10.1080/14660820510027035

Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev; 2012. (3):CD001447. DOI: 10.1002/14651858.CD001447

Li M, Guo K, Ikehara S. Stem cell treatment for Alzheimer’s disease. Int J Mol Sci; 2014. 15(10):19226-19238. DOI: 10.3390/ijms151019226

Upadhyay G, Shankar S, Srivastava RK. Stem cells in neurological disorders: Emerging therapy with stunning hopes. Mol Neurobiol; 2015. 52(1):610-625. DOI: 10.1007/s12035-014-8883-6

Levy YS, Stroomza M, Melamed E, Offen D. Embryonic and adult stem cells as a source for cell therapy in Parkinson’s disease. J Mol Neurosci MN; 2004. 24(3):353-386. DOI: 10.1385/JMN:24:3:353

Beers DR, Henkel JS, Zhao W, Wang J, Huang A, Wen S, et al. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain J Neurol; 2011. 134(Pt 5):1293-1314. DOI: 10.1093/brain/awr074

Ruiz Castaneda M. Surface fixation: A new method of detecting certain immunological reactions. Proc Soc Exp Biol Med; 1950. 73(1):46-49.

Ruiz Castaneda M. Surface fixation as a practical method for diagnosis of brucellosis in man and animals. Proc Soc Exp Biol Med; 1953. 83(1):36-39. DOI: 10.3181/00379727-83-20257

Njoku-Obi AN. Serologic aspects of listeriosis: the antigen-fixation test. In: Symposium on listeric infection. 2nd ed. Montana State College, Bozeman; 1963. p. 223-226.

Ruíz Castañeda M. A simple test for detection of specific and unspecific immunological reactions in cancer. Arch Invest Med (Mex); 1980. 11(1):83-93. PMID: 7396635

Instituto de Alergias y Autoinmunidad Dr. Maximiliano Ruíz Castañeda A.C. Available from: Accessed November 2, 2020.

Ruiz-Castañeda M, Gutiérrez de Velásco-Hernández C, Gómez-Ortiz ME, Pillado-Hernández MT. [Antigenic treatment of patients with Down’s syndrome]. Bol Med Hosp Infant Mex; 1982. 39(12):778-780. PMID: 6220726

Ruiz-Castañeda M. [Urodiagnosis]. Bol Med Hosp Infant Mex; 1982. 39(12):781-783. PMID: 6220727

Oskarsson B, Gendron TF, Staff NP. Amyotrophic Lateral Sclerosis: An Update for 2018. Mayo Clin Proc; 2018. 93(11):1617-1628.

DOI: 10.1016/j.mayocp.2018.04.007

Tyndall AJ, Joly F, Carbonne B, Deligny CN, Farge DC. Pregnancy and childbirth after treatment with autologous hematopoietic stem cell transplantation for severe systemic sclerosis requiring parenteral nutrition. Ethical issues. Clin Exp Rheumatol; 2008. 26(6):1122-1124. PMID: 19210885

Alexander T, Arnold R, Hiepe F, Radbruch A. Resetting the immune system with immunoablation and autologous haematopoietic stem cell transplantation in autoimmune diseases. Clin Exp Rheumatol; 2016. 34(4 Suppl 98):53-57.

PMID: 27586805

Obradović D, Tukić L, Radovinović-Tasić S, Petrović B, Elez M, Ostojić G, et al. Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis -A 10-year follow-up of the first transplanted patient. Vojnosanit Pregl; 2016. 73(5):504-508. DOI: 10.2298/VSP150304045O

Urushitani M, Ezzi SA, Julien J-P. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A; 2007. 104(7):2495-2500.

DOI: 10.1073/pnas.0606201104

Caballero-Hernández D, Toscano MG, Cejudo-Guillen M, García-Martin ML, López S, Franco JM, et al. The «Omics» of Amyotrophic Lateral Sclerosis. Trends Mol Med; 2016. 22(1):53-67.

DOI: 10.1016/j.molmed.2015.11.001

Liebau S, Vaida B, Storch A, Boeckers TM. Maturation of synaptic contacts in differentiating neural stem cells. Stem Cells; 2007. 25(7):1720-1729. DOI: 10.1634/stemcells.2006-0823

Li J, Lepski G. Cell transplantation for spinal cord injury: a systematic review. BioMed Res Int; 2013. 2013:786475. DOI: 10.1155/2013/786475

Riley J, Federici T, Polak M, Kelly C, Glass J, Raore B, et al. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: A phase I safety trial, technical note, and lumbar safety outcomes. Neurosurgery; 2012. 71(2):405-416.

DOI: 10.1227/NEU.0b013e31825ca05f

Xu L, Yan J, Chen D, Welsh AM, Hazel T, Johe K, et al. Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation; 2006. 82(7):865-875.

DOI: 10.1097/

Guo X, Johe K, Molnar P, Davis H, Hickman J. Characterization of a human fetal spinal cord stem cell line, NSI-566RSC, and its induction to functional motoneurons. J Tissue Eng Regen Med; 2010. 4(3):181-193. DOI: 10.1002/term.223

Borlongan CV, Evans A, Yu G, Hess DC. Limitations of intravenous human bone marrow CD133+ cell grafts in stroke rats. Brain Res; 2005. 1048(1-2):116-122. DOI: 10.1016/j.brainres.2005.04.087

Martínez HR, González-Garza MT, Moreno-Cuevas JE, Caro E, Gutiérrez-Jiménez E, Segura JJ. Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy; 2009. 11(1):26-34.

DOI: 10.1080/14653240802644651

Batista CE, Mariano ED, Marie SKN, Teixeira MJ, Morgalla M, Tatagiba M, et al. Stem cells in neurology--current perspectives. Arq Neuropsiquiatr; 2014. 72(6):457-465. DOI: 10.1590/0004-282x20140045.

Glass JD, Boulis NM, Johe K, Rutkove SB, Federici T, Polak M, et al. Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: Results of a phase I trial in 12 patients. Stem Cells; 2012. 30(6):1144-1151.

DOI: 10.1002/stem.1079

Mayaux J, Lambert J, Morélot-Panzini C, Gonzalez-Bermejo J, Delemazure J, Llontop C, et al. Survival of amyotrophic lateral sclerosis patients after admission to the intensive care unit for acute respiratory failure: an observational cohort study. J Crit Care; 2019. 50:54-58. DOI: 10.1016/j.jcrc.2018.11.007

Vianello A, Arcaro G, Palmieri A, Ermani M, Braccioni F, Gallan F, et al. Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis. J Crit Care; 2011. 26(3):329.e7-14.

DOI: 10.1016/j.jcrc.2010.06.003

Spataro R, Bono V, Marchese S, La Bella V. Tracheostomy mechanical ventilation in patients with amyotrophic lateral sclerosis: Clinical features and survival analysis. J Neurol Sci; 2012. 323(1-2):66-70. DOI: 10.1016/j.jns.2012.08.011

Ulhaq Z. Aromatase and neuroregeneration. MNJ (Malang Neurology Journal); 2019. 5(1):48-50.

DOI: 10.21776/ub.mnj.2019.005.01.9

Antunes J, Karvat J, Bernardino G, Kakihata C, Brancalhão R, Ribeiro L, et al. Histological analysis of wistar rats sciatic nerves subjected to compression and treated with low level laser therapy and neural mobilization. MNJ (Malang Neurology Journal); 2019. 5(2):55-60.

DOI: 10.21776/ub.mnj.2019.005.02.1


  • There are currently no refbacks.